NCT06974929View on ClinicalTrials.gov

A Clinical Study of HRS-6209 in Combination With Letrozole in Patients With Breast Cancer

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 22, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Breast Cancer
Interventions
DRUG

HRS-6209 Capsules

Oral HRS-6209 capsules.

DRUG

Letrozole Tablets

Oral Letrozole tablets.

Trial Locations (1)

300060

RECRUITING

Tianjin Medical University Cancer Institute and Hospital, Tianjin

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY